USE OF MOUTHWASH AND DENTIFRICE CONTAINING AN ANTIMICROBIAL PHTHALOCYANINE DERIVATIVE FOR THE REDUCTION OF CLINICAL SYMPTOMS OF COVID-19: A RANDOMIZED TRIPLE-BLIND CLINICAL TRIAL

PURPOSE: This clinical trial aimed to evaluate the use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative (APD) to reduce the clinical symptoms in patients with COVID-19. METHODS: This randomized, triple-blind clinical trial enrolled 134 patients aged 18 years or older...

Descripción completa

Detalles Bibliográficos
Autores principales: Poleti, Marcelo Lupion, Gregório, Danielle, Bistaffa, Alisson Gabriel Idelfonso, Fernandes, Karen Barros Parron, Vilhena, Fabiano Vieira, Santos, Paulo Sérgio da Silva, Simão, Andréa Name Colado, Lozovoy, Marcell Alysson Batisti, Tatibana, Berenice Tomoko, Fernandes, Thais Maria Freire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472577/
https://www.ncbi.nlm.nih.gov/pubmed/36494114
http://dx.doi.org/10.1016/j.jebdp.2022.101777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472577/
https://www.ncbi.nlm.nih.gov/pubmed/36494114
http://dx.doi.org/10.1016/j.jebdp.2022.101777

Ejemplares similares